Photo of Afshan A. Nanji, M.D., M.P.H.

Afshan A. Nanji M.D., M.P.H.

  • (503) 494-7674
    • Assistant Professor of Ophthalmology School of Medicine
    • Casey Eye Institute School of Medicine

Dr. Nanji specializes in corneal and external diseases, ocular surface oncology, laser vision correction/LASIK, cataract and intraocular lenses. She has special interests in conjunctival and corneal tumors as well as in international ophthalmology. Outside of work, Dr. Nanji enjoys traveling, hiking, and reading.

Education

  • B.A., Princeton University, Princeton New Jersey 2002
  • M.P.H., Johns Hopkins Bloomberg School of Public Health, Baltimore Maryland 2008
  • M.D., Johns Hopkins University School of Medicine, Baltimore Maryland 2008
  • Residency:

    • Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, MD
  • Fellowship:

    • Cornea, Bascom Palmer Eye Institute, University of Miami, Miami, FL
  • Certifications:

    • American Board of Ophthalmology

Publications

  • "Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae" Genetics October 2007
  • "Inadvertent trypan blue posterior capsule staining during cataract surgery" American Journal of Ophthalmology April 2013
  • "Management of conjunctival malignant melanoma" Expert Review of Ophthalmology  2014
  • "Ultra high-resolution anterior segment optical coherence tomography in the diagnosis and management of ocular surface squamous neoplasia" Ocular Surface January 2014
  • "Surgical versus medical treatment of ocular surface squamous neoplasia" Ophthalmology  2014
  • "Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery" The Cochrane database of systematic reviews  2007
  • "Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery." The Cochrane database of systematic reviews  2013
  • "Nonarteritic anterior ischemic optic neuropathy in a child with optic disk drusen" Journal of AAPOS April 2012
  • "Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion" The Cochrane database of systematic reviews  2008
  • "Human Papilloma Virus Infection Does Not Predict Response to Interferon Therapy in Ocular Surface Squamous Neoplasia" Ophthalmology April 13 2015
  • "Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion." The Cochrane database of systematic reviews  2010
  • "Topical chemotherapy for ocular surface squamous neoplasia" Current Opinion in Ophthalmology July 2013
  • "High-Resolution Optical Coherence Tomography as an Adjunctive Tool in the Diagnosis of Corneal and Conjunctival Pathology" Ocular Surface July 1 2015
  • "Surgical versus medical treatment of ocular surface squamous neoplasia a cost comparison" Ophthalmology March 1 2016
  • "Author reply" Ophthalmology December 1 2014
  • "Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion" The Cochrane database of systematic reviews  2014
  • "Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery" The Cochrane database of systematic reviews February 13 2017
  • "Updates in ocular surface tumor diagnostics" International Ophthalmology Clinics  2017
  • "Role of high resolution optical coherence tomography in diagnosing ocular surface squamous neoplasia with coexisting ocular surface diseases" Ocular Surface October 6 2016
  • "Ability of novice clinicians to interpret high-resolution optical coherence tomography for ocular surface lesions" Canadian Journal of Ophthalmology January 1 2017

Additional information

Edit profile